• Valayannopoulos V, Wijburg FA. Therapy for the mucopolysaccharidoses. Rheumatology (Oxford) 2011;50 Suppl 5:v49-59.
  • Schiff M, Broue P, Chabrol B, De Laet C, Habes D, Mention K, et al. Heterogeneity of follow-up procedures in French and Belgian patients with treated hereditary tyrosinemia type 1: results of a questionnaire and proposed guidelines. J Inherit Metab Dis 2011.
  • Djouadi F, Bastin J. Species differences in the effects of bezafibrate as a potential treatment of mitochondrial disorders. Cell Metab 2011;14:715-6; author reply 717.
  • Hendriksz CJ, Giugliani R, Harmatz P, Lampe C, Martins AM, Pastores GM, et al. Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP). J Inherit Metab Dis 2011.
  • Cheliout-Heraut F, Senny F, Djouadi F, Ouayoun M, Bour F. Obstructive sleep apnoea syndrome: comparison between polysomnography and portable sleep monitoring based on jaw recordings. Neurophysiol Clin 2011;41:191-8.
  • Hussain K, Challis B, Rocha N, Payne F, Minic M, Thompson A, et al. An activating mutation of AKT2 and human hypoglycemia. Science 2011;334:474.
  • Henquin JC, Nenquin M, Sempoux C, Guiot Y, Bellanné-Chantelot C, Otonkoski T, et al. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions. J Clin Invest 2011;121:3932-42.
  • Arnoux JB, Verkarre V, Saint-Martin C, Montravers F, Brassier A, Valayannopoulos V, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 2011;6:63.
  • Sempoux C, Capito C, Bellanné-Chantelot C, Verkarre V, de Lonlay P, Aigrain Y, et al. Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. J Clin Endocrinol Metab 2011;96:3785-93.
  • Imbard A, Boutron A, Vequaud C, Zater M, de Lonlay P, de Baulny HO, et al. Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein. Mol Genet Metab 2011;104:507-16.
  • Valayannopoulos V, Brassier A, Chabli A, Caillaud C, Lemoine M, Odent T, et al. Le traitement par enzymothérapie des maladies lysosomales. Arch Pediatr 2011;18:1119-23.
  • Valayannopoulos V, Bajolle F, Arnoux JB, Dubois S, Sannier N, Baussan C, et al. Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet. Pediatr Res 2011;70:638-41.
  • Sloan JL, Johnston JJ, Manoli I, Chandler RJ, Krause C, Carrillo-Carrasco N, et al. Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria. Nat Genet 2011;43:883-6.
  • de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 2011;6:55.
  • Milh M, Villeneuve N, Chouchane M, Kaminska A, Laroche C, Barthez MA, et al. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations. Epilepsia 2011;52:1828-34.
  • Davit-Spraul A, Piraud M, Dobbelaere D, Valayannopoulos V, Labrune P, Habes D, et al. Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies. Mol Genet Metab 2011;104:137-43.
  • Ottolenghi C, Hubert L, Allanore Y, Brassier A, Altuzarra C, Mellot-Draznieks C, et al. Clinical and biochemical heterogeneity associated with fumarase deficiency. Hum Mutat 2011.
  • Boutron A, Acquaviva C, Vianey-Saban C, de Lonlay P, de Baulny HO, Guffon N, et al. Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency. Mol Genet Metab 2011;103:341-8.
  • Kelly-Aubert M, Trudel S, Fritsch J, Nguyen-Khoa T, Baudouin-Legros M, Moriceau S, et al. GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models. Hum Mol Genet 2011;20:2745-59.
  • Powell PD, Bellanné-Chantelot C, Flanagan SE, Ellard S, Rooman R, Hussain K, et al. In vitro recovery of ATP-sensitive potassium channels in ?-cells from patients with congenital hyperinsulinism of infancy. Diabetes 2011;60:1223-8.
  • Bastin J, Lopes-Costa A, Djouadi F. Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts. Hum Mol Genet 2011;20:2048-57.
  • Muenzer J, Beck M, Giugliani R, Suzuki Y, Tylki-Szymanska A, Valayannopoulos V, et al. Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey. Genet Med 2011;13:102-9.
  • Héron B, Mikaeloff Y, Froissart R, Caridade G, Maire I, Caillaud C, et al. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 2011;155A:58-68.
  • Capito C, de Lonlay P, Verkarre V, Jaubert F, Rahier J, Nihoul-Fékété C, et al. The surgical management of atypical forms of congenital hyperinsulinism. Semin Pediatr Surg 2011;20:54-5.
  • Saint-Martin C, Arnoux JB, de Lonlay P, Bellanné-Chantelot C. KATP channel mutations in congenital hyperinsulinism. Semin Pediatr Surg 2011;20:18-22.
  • Barthlen W, de Lonlay P. Congenital hyperinsulinism. Semin Pediatr Surg 2011;20:1-2.
  • Ramos HE, Morandini M, Carré A, Tron E, Floch C, Mandelbrot L, et al. Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care. Eur J Endocrinol 2011;164:309-14.
  • Desbrée A, Houdon L, Touati G, Djemili S, Choker G, Flodrops H. Infection à EBV révélatrice à l'âge de 3ans d'un déficit en 3-hydroxyacyl-CoA déshydrogénase des acides gras à chaîne longue (LCHAD). Arch Pediatr 2011;18:18-22.
  • Lebre AS, Rio M, Faivre d'Arcier L, Vernerey D, Landrieu P, Slama A, et al. A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet 2011;48:16-23.
  • Ismail D, Smith VV, de Lonlay P, Ribeiro MJ, Rahier J, Blankenstein O, et al. Familial focal congenital hyperinsulinism. J Clin Endocrinol Metab 2011;96:24-8.
  • Betsalel OT, Rosenberg EH, Almeida LS, Kleefstra T, Schwartz CE, Valayannopoulos V, et al. Characterization of novel SLC6A8 variants with the use of splice-site analysis tools and implementation of a newly developed LOVD database. Eur J Hum Genet 2011;19:56-63.
  • Barth M, Ottolenghi C, Hubert L, Chrétien D, Serre V, Gobin S, et al. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. J Inherit Metab Dis 2010.
  • Valayannopoulos V, de Blic J, Mahlaoui N, Stos B, Jaubert F, Bonnet D, et al. Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation. Pediatrics 2010;126:e1242-7.
  • Bellanné-Chantelot C, Saint-Martin C, Ribeiro MJ, Vaury C, Verkarre V, Arnoux JB, et al. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. J Med Genet 2010;47:752-9.
  • Dupré T, Vuillaumier-Barrot S, Chantret I, Yayé HS, Le Bizec C, Afenjar A, et al. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations. J Med Genet 2010;47:729-35.
  • Bouchireb K, Teychene AM, Rigal O, de Lonlay P, Valayannopoulos V, Gaudelus J, et al. Post-mortem MRI reveals CPT2 deficiency after sudden infant death. Eur J Pediatr 2010;169:1561-3.
  • de Lonlay P, Valayannopoulos V, Arnoux JB, Servais A, Charron B, Jacqmarcq O, et al. Démarche diagnostique et thérapeutique d'une maladie métabolique en anesthésie-réanimation. Arch Pediatr 2010;17:947-8.
  • Peric D, Durrant-Arico C, Delenda C, Dupré T, De Lonlay P, de Baulny HO, et al. The compartmentalisation of phosphorylated free oligosaccharides in cells from a CDG Ig patient reveals a novel ER-to-cytosol translocation process. PLoS One 2010;5:e11675.
  • Léticée N, Bessières-Grattagliano B, Dupré T, Vuillaumier-Barrot S, de Lonlay P, Razavi F, et al. Should PMM2-deficiency (CDG Ia) be searched in every case of unexplained hydrops fetalis? Mol Genet Metab 2010;101:253-7.
  • Flamand-Rouvière C, Guettard E, Moreau C, Bahi-Buisson N, Valayannopoulos V, Grabli D, et al. Speech disturbances in patients with dystonia or chorea due to neurometabolic disorders. Mov Disord 2010;25:1605-11.
  • Rio M, Lebre AS, de Lonlay P, Valayannopoulos V, Desguerre I, Dufier JL, et al. Mitochondrial ND5 mutations mimicking brainstem tectal glioma. Neurology 2010;75:93.
  • Engelke UF, Zijlstra FS, Mochel F, Valayannopoulos V, Rabier D, Kluijtmans LA, et al. Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency. Biochim Biophys Acta 2010;1802:1028-35.
  • Michot C, Hubert L, Brivet M, De Meirleir L, Valayannopoulos V, Müller-Felber W, et al. LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood. Hum Mutat 2010;31:E1564-73.
  • Mills PB, Footitt EJ, Mills KA, Tuschl K, Aylett S, Varadkar S, et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 2010;133:2148-59.
  • Arnoux JB, de Lonlay P, Ribeiro MJ, Hussain K, Blankenstein O, Mohnike K, et al. Congenital hyperinsulinism. Early Hum Dev 2010;86:287-94.
  • Guilmatre A, Legallic S, Steel G, Willis A, Di Rosa G, Goldenberg A, et al. Type I hyperprolinemia: genotype/phenotype correlations. Hum Mutat 2010;31:961-5.
  • Bonnefont JP, Bastin J, Laforêt P, Aubey F, Mogenet A, Romano S, et al. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. Clin Pharmacol Ther 2010;88:101-8.
  • Willemsen MA, Verbeek MM, Kamsteeg EJ, de Rijk-van Andel JF, Aeby A, Blau N, et al. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 2010;133:1810-22.
  • Valayannopoulos V, Nicely H, Harmatz P, Turbeville S. Mucopolysaccharidosis VI. Orphanet J Rare Dis 2010;5:5.
  • Boddaert N, Desguerre I, Bahi-Buisson N, Romano S, Valayannopoulos V, Saillour Y, et al. Posterior fossa imaging in 158 children with ataxia. J Neuroradiol 2010;37:220-30.
  • Schiff M, Ogier de Baulny H, Bard G, Barlogis V, Hamel C, Moat SJ, et al. Should transcobalamin deficiency be treated aggressively? J Inherit Metab Dis 2010;33:223-9.
  • Valayannopoulos V, Haudry C, Serre V, Barth M, Boddaert N, Arnoux JB, et al. New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria. Mitochondrion 2010;10:335-41.
  • El Sabbagh S, Lebre AS, Bahi-Buisson N, Delonlay P, Soufflet C, Boddaert N, et al. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia 2010;51:1225-35.
  • Valayannopoulos V, Boddaert N, Barbier V, Le Merrer M, Caillaud C, de Lonlay P. Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase. Mol Genet Metab 2010;100:20-3.
  • Steenweg ME, Jakobs C, Errami A, van Dooren SJ, Adeva Bartolomé MT, Aerssens P, et al. An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum Mutat 2010;31:380-90.
  • Barnerias C, Saudubray JM, Touati G, De Lonlay P, Dulac O, Ponsot G, et al. Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol 2010;52:e1-9.
  • Pierron S, Giudicelli H, Moreigne M, Khalfi A, Touati G, Caruba C, et al. Déficit en 3-HMG-CoA lyase à révélation tardive : savoir reconnaître une maladie rare mais traitable. Arch Pediatr 2010;17:10-3.
  • Romano S, Valayannopoulos V, Touati G, Jais JP, Rabier D, de Keyzer Y, et al. Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr 2010;156:128-34.
  • Campeau PM, Valayannopoulos V, Touati G, Bahi-Buisson N, Boddaert N, Plouin P, et al. Management of West syndrome in a patient with methylmalonic aciduria. J Child Neurol 2010;25:94-7.
  • Mougou-Zerelli S, Thomas S, Szenker E, Audollent S, Elkhartoufi N, Babarit C, et al. CC2D2A mutations in Meckel and Joubert syndromes indicate a genotype-phenotype correlation. Hum Mutat 2009;30:1574-82.
  • Travaglini L, Brancati F, Attie-Bitach T, Audollent S, Bertini E, Kaplan J, et al. Expanding CEP290 mutational spectrum in ciliopathies. Am J Med Genet A 2009;149A:2173-80.
  • Munnich A, de Lonlay P, Rötig A, Rustin P. Cytopathies mitochondriales. Bull Acad Natl Med 2009;193:19-41; discussion 41-3.
  • Capito C, Khen-Dunlop N, Ribeiro MJ, Brunelle F, Aigrain Y, Crétolle C, et al. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism. Radiology 2009;253:216-22.
  • Puget S, Garnett MR, Leclercq D, Pinto-Primard G, Samara-Boustani D, Sainte-Rose C, et al. Hypothalamic lipoma associated with severe obesity. Report of 2 cases. J Neurosurg Pediatr 2009;4:147-50.
  • Valayannopoulos V, Arnoux JB, Rio M, de Lonlay P. Conduite à tenir devant une acidose lactique. Arch Pediatr 2009;16:637-9.
  • Brahimi N, Jambou M, Sarzi E, Serre V, Boddaert N, Romano S, et al. The first founder DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome. Mol Genet Metab 2009;97:221-6.
  • Cosson MA, Benoist JF, Touati G, Déchaux M, Royer N, Grandin L, et al. Long-term outcome in methylmalonic aciduria: a series of 30 French patients. Mol Genet Metab 2009;97:172-8.
  • Romano S, Bajolle F, Valayannopoulos V, Lyonnet S, Colomb V, de Baracé C, et al. Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia). J Med Genet 2009;46:287-8.
  • Valayannopoulos V, Boddaert N, Mention K, Touati G, Barbier V, Chabli A, et al. Secondary creatine deficiency in ornithine delta-aminotransferase deficiency. Mol Genet Metab 2009;97:109-13.
  • de Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F, Hubert L, et al. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res 2009;66:91-5.
  • Monnot S, Serre V, Chadefaux-Vekemans B, Aupetit J, Romano S, De Lonlay P, et al. Structural insights on pathogenic effects of novel mutations causing pyruvate carboxylase deficiency. Hum Mutat 2009;30:734-40.
  • Valayannopoulos V, Hubert L, Benoist JF, Romano S, Arnoux JB, Chrétien D, et al. Multiple OXPHOS deficiency in the liver of a patient with CblA methylmalonic aciduria sensitive to vitamin B(12). J Inherit Metab Dis 2009;32:159-62.
  • Bonnefond A, Bouatia-Naji N, Simon A, Saint-Martin C, Dechaume A, de Lonlay P, et al. Mutations in G6PC2 do not contribute to monogenic forms of early infancy diabetes and beta cell dysfunction. Diabetologia 2009;52:982-5.
  • de Lonlay P, Seta N. The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. Biochim Biophys Acta 2009;1792:841-3.
  • Atale A, Bonneau-Amati P, Rötig A, Fischer A, Perez-Martin S, de Lonlay P, et al. Tubulopathy and pancytopaenia with normal pancreatic function: a variant of Pearson syndrome. Eur J Med Genet 2009;52:23-6.
  • Gitiaux C, Ceballos-Picot I, Marie S, Valayannopoulos V, Rio M, Verrieres S, et al. Misleading behavioural phenotype with adenylosuccinate lyase deficiency. Eur J Hum Genet 2009;17:133-6.
  • Flanagan SE, Clauin S, Bellanné-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, et al. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2009;30:170-80.
  • González-Barroso MM, Giurgea I, Bouillaud F, Anedda A, Bellanné-Chantelot C, Hubert L, et al. Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion. PLoS One 2008;3:e3850.
  • Bahi-Buisson N, Roze E, Dionisi C, Escande F, Valayannopoulos V, Feillet F, et al. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol 2008;50:945-9.
  • Gitiaux C, Roze E, Kinugawa K, Flamand-Rouvière C, Boddaert N, Apartis E, et al. Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord 2008;23:2392-7.
  • Khen-Dunlop N, Capito C, Valayannopoulos V, Elie C, Ribeiro MJ, Rahier J, et al. Predictive value of postoperative glycosuria after partial elective pancreatectomy in focal congenital hyperinsulinism. Diabetes Care 2008;31:e71.
  • Zeharia A, Shaag A, Houtkooper RH, Hindi T, de Lonlay P, Erez G, et al. Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am J Hum Genet 2008;83:489-94.
  • Damaj L, le Lorch M, Verkarre V, Werl C, Hubert L, Nihoul-Fékété C, et al. Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism. J Clin Endocrinol Metab 2008;93:4941-7.
  • Cosson MA, Touati G, Lacaille F, Valayannnopoulos V, Guyot C, Guest G, et al. Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria. Mol Genet Metab 2008;95:107-9.
  • Brunelle F, Ribeiro M, Boddaert N, Nihoul-Fekete C, Jaubert F, Rahier J, et al. Hyperinsulinisme chez l'enfant: nouveaux concepts--rôle de l'imagerie. Bull Acad Natl Med 2008;192:59-70; discussion 71-2.
  • Laugel V, Dalloz C, Tobias ES, Tolmie JL, Martin-Coignard D, Drouin-Garraud V, et al. Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation. J Med Genet 2008;45:564-71.
  • de Lonlay P, Valayannopoulos V, Dupré T, Vuillaumier-Barrot S, Seta N. Anomalies congénitales de glycosylation. Arch Pediatr 2008;15:602-5.
  • Wamelink MM, Struys EA, Valayannopoulos V, Gonzales M, Saudubray JM, Jakobs C. Retrospective detection of transaldolase deficiency in amniotic fluid: implications for prenatal diagnosis. Prenat Diagn 2008;28:460-2.
  • Bahi-Buisson N, El Sabbagh S, Soufflet C, Escande F, Boddaert N, Valayannopoulos V, et al. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure 2008;17:658-64.
  • Mollet J, Delahodde A, Serre V, Chretien D, Schlemmer D, Lombes A, et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 2008;82:623-30.
  • Barnerias C, Boddaert N, Guiraud P, Pascale G, Desguerre I, Isabelle D, et al. Unusual magnetic resonance imaging features in Menkes disease. Brain Dev 2008;30:489-92.
  • Masurel-Paulet A, Poggi-Bach J, Rolland MO, Bernard O, Guffon N, Dobbelaere D, et al. NTBC treatment in tyrosinaemia type I: long-term outcome in French patients. J Inherit Metab Dis 2008;31:81-7.
  • Desguerre I, Marti I, Valayannopoulos V, Bahi-Buisson N, Dulac O, Plouin P, et al. Transient magnetic resonance diffusion abnormalities in West syndrome: the radiological expression of non-convulsive status epilepticus? Dev Med Child Neurol 2008;50:112-6.
  • Arnoux JB, Boddaert N, Valayannopoulos V, Romano S, Bahi-Buisson N, Desguerre I, et al. Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia. Mol Genet Metab 2008;93:444-9.
  • Boichard A, Venet L, Naas T, Boutron A, Chevret L, de Baulny HO, et al. Two silent substitutions in the PDHA1 gene cause exon 5 skipping by disruption of a putative exonic splicing enhancer. Mol Genet Metab 2008;93:323-30.
  • Romano S, Samara D, Crosnier H, Valayannopoulos V, Polak M, Chrétien D, et al. Variable outcome of growth hormone administration in respiratory chain deficiency. Mol Genet Metab 2008;93:195-9.
  • Boddaert N, Romano S, Funalot B, Rio M, Sarzi E, Lebre AS, et al. 1H MRS spectroscopy evidence of cerebellar high lactate in mitochondrial respiratory chain deficiency. Mol Genet Metab 2008;93:85-8.
  • Mention K, Lacaille F, Valayannopoulos V, Romano S, Kuster A, Cretz M, et al. Development of liver disease despite mannose treatment in two patients with CDG-Ib. Mol Genet Metab 2008;93:40-3.
  • Valayannopoulos V, Romano S, Mention K, Vassault A, Rabier D, Polak M, et al. What's new in metabolic and genetic hypoglycaemias: diagnosis and management. Eur J Pediatr 2008;167:257-65.
  • Desguerre I, Barnerias C, Valayannopoulos V. Les neuropathies périphériques révélatrices de maladies métaboliques chez l'enfant. Rev Neurol (Paris) 2007;163:1256-9.
  • Ribeiro MJ, Boddaert N, Delzescaux T, Valayannopoulos V, Bellanné-Chantelot C, Jaubert F, et al. Functional imaging of the pancreas: the role of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy. Endocr Dev 2007;12:55-66.
  • Bahi-Buisson N, Eisermann M, Nivot S, Bellanné-Chantelot C, Dulac O, Bach N, et al. Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2. J Child Neurol 2007;22:1147-50.
  • Ribeiro MJ, Boddaert N, Bellanné-Chantelot C, Bourgeois S, Valayannopoulos V, Delzescaux T, et al. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging 2007;34:2120-8.
  • Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debré M, et al. Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med 2007;356:2700-3.
  • Hussain K, Blankenstein O, De Lonlay P, Christesen HT. Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management. Arch Dis Child 2007;92:568-70.
  • Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 2007;39:776-80.
  • Sarzi E, Bourdon A, Chrétien D, Zarhrate M, Corcos J, Slama A, et al. Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood. J Pediatr 2007;150:531-4, 534.e1-6.
  • Valayannopoulos V, Vaxillaire M, Aigrain Y, Jaubert F, Bellanné-Chantelot C, Ribeiro MJ, et al. Coexistence in the same family of both focal and diffuse forms of hyperinsulinism. Diabetes Care 2007;30:1590-2.
  • Mollet J, Giurgea I, Schlemmer D, Dallner G, Chretien D, Delahodde A, et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 2007;117:765-72.
  • Delonlay P, Simon A, Galmiche-Rolland L, Giurgea I, Verkarre V, Aigrain Y, et al. Neonatal hyperinsulinism: clinicopathologic correlation. Hum Pathol 2007;38:387-99.
  • Baala L, Romano S, Khaddour R, Saunier S, Smith UM, Audollent S, et al. The Meckel-Gruber syndrome gene, MKS3, is mutated in Joubert syndrome. Am J Hum Genet 2007;80:186-94.
  • Miné M, Chen JM, Brivet M, Desguerre I, Marchant D, de Lonlay P, et al. A large genomic deletion in the PDHX gene caused by the retrotranspositional insertion of a full-length LINE-1 element. Hum Mutat 2007;28:137-42.
  • Jouvet P, Touati G, Lesage F, Dupic L, Tucci M, Saudubray JM, et al. Impact of inborn errors of metabolism on admission and mortality in a pediatric intensive care unit. Eur J Pediatr 2007;166:461-5.